tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Advertisement

GlaxoSmithKline (GSK) Drug Pipeline

Compare
5,102 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Comparator 1, Comparator 2, Comparator 3, Flu Mrna (Formulation B1), Flu Mrna (Formulation B3), Flu Mrna(Formulation A)
Influenza, Human
Phase II
Not Yet Recruiting
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
Oct 01, 2025
Depemokimab
Pulmonary Disease, Chronic Obstructive
Phase III
Not Yet Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sep 15, 2025
Bepirovirsen
Hepatitis B
Phase I
Not Yet Recruiting
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Sep 10, 2025
Lenalidomide, Dexamethasone, Belantamab Mafodotin, Nirogacestat
Multiple Myeloma
Phase I/II
Active Not Recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
Aug 25, 2025
Dexamethasone, Pomalidomide, Belantamab Mafodotin, Nirogacestat
Multiple Myeloma
Phase I/II
Active Not Recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
Aug 25, 2025
Comparator 1, Comparator 2, Flu Mrna (Formulation A), Flu Mrna (Formulation B), Comparator 3
Influenza, Human
Phase II
Not Yet Recruiting
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
Aug 06, 2025
Carboplatin, Paclitaxel, Dostarlimab
Neoplasms, Endometrial
Phase II
Not Yet Recruiting
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)
Aug 05, 2025
Pcv20, Pn-Maps30plus
Pneumonia, Bacterial
Phase I
Recruiting
A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age
Aug 04, 2025
Gsk4527226
Alzheimer's Disease
Phase II
Not Yet Recruiting
Open-label Extension Study in Participants With Early Alzheimer's Disease
Aug 01, 2025
Gsk5764227, Topotecan
Neoplasms, Lung
Phase III
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Jul 30, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does GlaxoSmithKline (GSK) have in its pipeline
      GSK is currently developing the following drugs: Comparator 1, Comparator 2, Comparator 3, Flu Mrna (Formulation B1), Flu Mrna (Formulation B3), Flu Mrna(Formulation A), Depemokimab, Bepirovirsen. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis